Skip to main content

Study

Folic Acid and Vitamin B12 Improve Cognitive Function in Alzheimer's Patients

Supplementing with folic acid and vitamin B12 may boost memory and reduce inflammation in Alzheimer's patients.

Brain HealthMemory SupportHealthy AgingSupplements
Study Credibility: High7.5/10From a trusted journalProperly designed studyResults verified
PublishedSep 2026Last reviewedSep 2026
Email this

Summary

In plain language

Recent research has shown that taking folic acid and vitamin B12 together can help improve memory and reduce inflammation in individuals with Alzheimer's disease. In the study, patients who took these vitamins daily for six months saw improvements in areas such as orientation and attention compared to those who did not. The study also found that this combination of vitamins reduced levels of certain inflammatory markers in the blood. This research suggests that integrating these vitamins into the diet could be beneficial for those dealing with Alzheimer's, especially if they are not already consuming fortified foods.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study involved 120 Alzheimer's patients who were given either a combination of folic acid and vitamin B12 or a placebo for six months. The researchers measured cognitive performance and inflammation levels before and after the intervention.

  • The study found that those receiving the vitamins showed better cognitive performance, with notable improvements in memory and attention.

  • Inflammation markers in the blood, which are associated with Alzheimer's progression, were significantly lower in the vitamin group.

  • While results are promising, the study was limited to patients not on a folate-fortified diet, indicating results may vary based on diet.

Seniors interested in this approach should talk to their healthcare providers to see if these supplements could be beneficial for them.

Research Quality Score

Scored September 28, 2026 using rubric mq-1.8_2026-07-06.

Assessment

The study's strengths include its randomized controlled design and comprehensive statistical analysis, which support its findings. However, the lack of allocation concealment and incomplete transparency regarding data sharing limit its bias control and transparency scores. The absence of replication evidence and unspecified journal quality also affect the overall score.

Category Breakdown

CategoryScoreRating
Study design10.0/10
Bias control6.7/10
Statistical methods10.0/10
Reporting completeness5.0/10
Conflicts & funding10.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

This randomized, single-blind, placebo-controlled trial evaluated the effects of folic acid and vitamin B12 supplementation on cognitive function and inflammation in Alzheimer's patients. The intervention improved cognitive scores and reduced inflammatory markers over six months.

Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were reviewed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.